When iPhone and iPad users fire up iOS 6 this fall, one of the biggest changes they'll notice is an absence of Apple's competitor Google.
Not only has Apple created its own version of maps to replace the Google Maps app in iOS 6, but it's nixed the native YouTube app--a feature that has been included in iOS since its beginning.
Apple had this to say about the omission: “Our license to include the YouTube app in iOS has ended, customers can use YouTube in the Safari browser and Google is working on a new YouTube app to be on the App Store."
It's not clear which side (or both) prevented a renewal of the agreement, though The Verge interprets the situation as "more evidence that the two companies want to kill one another." In other words, The Great Tech War Of 2012 continues.
You'll still be able to download Google apps to your iOS devices, of course, but YouTube and Maps will no longer come pre-installed. The good news, if you like watching YouTube on your Apple device, is that the YouTube mobile website is more robust than its abandoned native app counterpart anyhow.
September Launch Date For New Nokia Windows Phone?
Word is, Nokia may be coming out with a phone in early September, just in time to meet Microsoft's new Windows 8 OS.
Tipsters have told Bloomberg that Nokia will be showing the phones off for the first time at the Nokia World event in Helsinki that takes place over September 5 and 6. If that's true, Nokia could have its phone out before Apple unveils its new iPhone, itself rumored to be out in mid-September.
But that's not all. An independent rumor bubbling up at the website Know Your Mobile via Concept Phones suggests that a future "Nokia Lumia X" device may have an optical zoom feature built into a rotating top. If that's true--that could separate this mythical Nokia's Lumia X model from other high-end smartphones which largely rely on lower quality digital zoom.
Shark Week, Thunderclap Form Voltron Of Awesomeness
Pledge a tweet, save a shark.
Discovery Channel's Shark Week is teaming up with Thunderclap to give its social campaign some extra bite. Shark Week is supporting three shark conservation groups--the Pew Environment Group, Oceana and Shark Savers. Regular shark lovers can rally behind the the trio this season and back a shark extinction awareness campaign on Twitter or Facebook. "The more that join, the louder Shark Week conservation efforts will be heard worldwide," the groups explain on their Thunderclap campaign page, which TheNextWeb noticed had gone up today.
This partnership with Shark Week comes at a good time for Thunderclap, which just got out of rough water with Twitter. When Thunderclap first launched, Twitter shut it down, perceiving a threat to its own Promoted Tweets. But Thunderclap bounced back, taking its business to Facebook and convinced Twitter to changed its mind too. Discovery Channel's Shark Week is a perennial hit, and likely to serve the new service well. Thunderclap allows fans of a brand to pledge tweets or Facebook posts towards to support it. If the campaign hits the target number of pledges, Thunderclap sends out a mass message turning the event or cause into a trending topic.
Look Who's Talking Now: Nuance Announces Voice-IDing Speech-To-Text Software
Nuance, makers of Siri, just introduced the world to their latest muse, "Nina." Though the two apparently sound the same, Nuance has added "voice biometrics" to Nina's list of talents as a voice-activated personal assistant. Like Siri, Nina identifies spoken phrases, but the difference is, Nina can tell who is speaking. Nuance explains that this means that Nina could work as an authentication tool, using voice ID instead of typed passwords. For example, when AllThingsD tested the app, Nina would only allow the one registered speaker to sign into its demo banking app. Nuance is letting Nina loose with a software development kit--a first for the company--giving developers the ability to integrate the software into mobile apps that use voice-activated customer service. This expands beyond Siri's coverage area, which falls primarily within Apple's own selection of apps. Nuance will pilot test Nina in August with the USAA, which provides banking facilities for the U.S. military. The plan is to give all USAA members access to Nina on their Android and iOS USAA apps early next year.
• Astellas Pharma Inc. (YPH.BE)'s Subsidiary Urogenix Inc. Shutting Down, 13 Scientists and Staff Affected More...
• KV Pharmaceutical Seeks Chap. 11 More...
• Proteros biostructures GmbH Announces Successful Close of 5 Million Euros More...
• GlaxoSmithKline (GSK) Completes $3.6 Billion Takeover of Human Genome Sciences, Inc. (HGSI) More...
• BC Partners to Acquire Aenova From Bridgepoint More...
• Kamada Ltd. (KMDA.TA) and Chiesi Farmaceutici SpA Enter into a Strategic Agreement for Up to $60 Million More...
• PharmaEngine, Inc. Nabs Rights to Nanobiotix's Nanoparticle Radiotherapy Booster for Up to $57 Million More...
• Novartis AG (NVS) Gets Immune-Cell Cancer Therapy in University of Pennsylvania Pact More...
• Tekmira Pharmaceuticals Corporation Provides Update on Collaboration With U.S. Government's TMT Program More...
• ACCU-BREAK Pharmaceuticals, Inc. Enters Into a Product Development and License Agreement With Alembic Pharmaceuticals Limited More...
• Nile Therapeutics, Inc. Promotes Darlene Horton, M.D., to Chief Executive Officer and Director More...
• Perreault Will Move Up to CEO of CSL Behring More...
• BioLargo, Inc. (BLGO.PK) Adds Wound Management Expert and Former VP at Smith & Nephew Inc. (SNN), Tanya Rhodes, to Its Team More...
• Champions Oncology, Inc. (CSBR) Reports Resignation of Director More...
• Eclipse Therapeutics, Inc., Sorrento Valley-Based Biotech Developing Innovative Cancer Therapeutics that Target Cancer Stem Cells, Appoints Patrick M. O'Connor, Ph.D. to Scientific Advisory Board More...
• Accellent Announces Timing of Second Quarter 2012 Earnings Release and Conference Call More...
• Celsion Corporation (CLN) to Hold Second Quarter 2012 Financial Results Conference Call on Tuesday, August 14, 2012 More...
• Cleveland Biolabs Inc. (CBLI) Reports Second Quarter 2012 Financial Results and Development Progress More...
• Cumberland Pharmaceuticals (CPIX) Reports Second Quarter 2012 Financial Results More...
• Depomed, Inc. (DEPO) Reports Second Quarter Financial Results More...
• Teva Pharmaceutical Industries Limited (TEVA) Subpoenaed Over Foreign Bribes More...
• U.S. Appeals Court Tosses Momenta Pharmaceuticals, Inc. (MNTA) Injunction Against Generic Lovenox More...
• CoreRx Opens Brand New 35,000 sq. ft. State-of-the-Art Facility More...
• FDA OKs First Generic Copies of Merck & Co., Inc. (MRK)'s Singulair More...
• Medivation, Inc. (MDVN) and Astellas Pharma Inc. (YPH.BE) Get PDUFA Date for Prostate Cancer Drug More...
• OXiGENE (OXGN) Announces Phase 2 Ovarian Cancer Trial of ZYBRESTAT® Plus Bevacizumab Achieves Important Interim Safety Objective More...
• TWi Pharmaceuticals, Inc. Announces Positive Phase IIb Clinical Trial Results of AC-201 in Patients With Type 2 Diabetes. More...
• Cellceutix (CTIX) Reports Its Very Novel Anti-Cancer Agent, Kevetrin, at Dana-Farber Cancer Institute for Start of Clinical Trials More...
• Alnylam Pharmaceuticals (ALNY) Presents New Data From Its Conjugate Delivery Platform, Enabling Subcutaneous Administration of RNAi Therapeutics With Wide Therapeutic Index More...
• Rexahn Pharmaceuticals, Inc. Completes Exploratory Phase I Clinical Study of RX-3117 More...
• The Way Your Pupils Dilate May Show Sexual Preference, Cornell University Study More...
• Carbon Monoxide's Damaging Role in Heart Rhythm Found, Leeds University Study More...
• Memory Improves for Older Adults Using Computerized Brain Fitness Program,University of California, Los Angeles (UCLA) Study More...
• Bilingualism "Can Increase Mental Agility," University of Strathclyde Study More...
• Honey May Ease Nighttime Coughing in Kids, Tel Aviv University Study More...
• Biostar Pharmaceuticals, Inc. (BSPM) Receives Approval From Xianyang SFDA to Restart Sales of Its Gel Capsule Drugs More...
• Mylan Inc. (MYL) Launches Generic Version of Amidate® Injection More...
• Qualitest Pharmaceuticals Launches Generic Singulair® More...
Knight Capital reportedly will receive $400M capital injection
Knight Capital Group is expected to avert bankruptcy after a group of investors agreed to put $400 million into the troubled securities firm, sources said. The capital injection will help Knight continue to operate after a software glitch last week led to a $440 million loss.
Spain delays bailout, waiting for ECB bond-buying data
Spanish Prime Minister Mariano Rajoy said he won't decide on whether to seek help from the eurozone's rescue fund until he learns more about the bond-buying plan that the European Central Bank is developing. "What I want to know is what these measures are, what they mean and whether they are appropriate and, in light of the circumstances, we will make a decision, but I have still not taken any decision," he said.
Greece's lenders report positive progress after visit
Representatives from the International Monetary Fund, the EU and the European Central Bank said talks with Greece about its recovery were productive. The troika is set to go back to Athens in September to assess the economy, a necessary step in Greece's process of repaying debt.
London emerges as global hub for oil-futures trading
Contracts for North Sea Brent crude set a record in June, according to ICE Futures Europe, topping trading in West Texas Intermediate oil on CME Group's New York Mercantile Exchange for a third straight month. That propelled London past New York for trading in oil futures.
Investors fret about U.S. "fiscal cliff"
Although markets have climbed recently, many investors say the shadow of automatic tax increases and spending cuts in the U.S. -- the so-called fiscal cliff -- is looming and worrying investors. "The quickly approaching fiscal cliff is big, scary [and] yet avoidable," said Bill Stone, PNC Wealth Management's chief investment strategist. Though most investors think a solution cannot be worked out before the presidential election in November, they also say that enough of a consensus exists to keep the nation from sailing off the edge.
Market Activity
Upbeat U.S. jobs news bolsters Asian-Pacific markets
Positive U.S. employment data and optimism that Europe is making progress with its sovereign-debt problems boosted Asian-Pacific exchanges Monday. Japan's Nikkei 225 and South Korea's Kospi each rose 2%. Australia's S&P/ASX 200 added 1.2%. Hong Kong's Hang Seng Index gained 1.7%. China's Shanghai Composite and Taiwan's Taiex each advanced 1%. India's Sensex was up 1.2% at midday.
Exchange for small companies is planned by NYSE Euronext
NYSE Euronext is working to launch a securities exchange intended to make it easier for small companies across Europe to offer stocks and bonds.
Wall Street braces for biggest week of IPOs since Facebook
The U.S. pipeline of initial public offerings has more deals set to come to market this week than at any time since Facebook's IPO. Capital-market adviser and data provider Ipreo said six companies will try to raise $1.1 billion.
Economics
U.S. manufacturers slash investment and hiring
The number of U.S. manufacturing firms canceling investment and delaying hiring is growing as executives anticipate that political deadlock will prevent Congress from heading off a "fiscal cliff" of tax hikes and spending cuts set to automatically take effect at year-end. Commerce Department data show that factory orders unexpectedly dropped 0.5% in June compared with May.
Shell reportedly shifts funds out of eurozone banks
Oil company Royal Dutch Shell is withdrawing some cash from eurozone banks to limit exposure to the debt crisis, according to The Times newspaper in London. "There's been a shift in our willingness to take credit risk in Europe. The crisis has impacted our willingness to afford credit," said Chief Financial Officer Simon Henry.
Analysis: Global food crisis might be taking shape
U.S. farmers normally provide more than half of the world's corn and 40% of its soybeans, but the worst drought in 50 years makes it impossible to save the corn crop, while there is some hope for soybeans, according to The Economist. "If the rains come too late to save America's soya harvest, a bad situation could become dire and hit the whole food sector, according to Abdolreza Abbassian of the UN Food and Agriculture Organisation," the magazine notes.
U.S. unemployment rises despite strongest hiring in 5 months
Employers added more workers in July than at any time in the past five months, but the unemployment rate still edged up, from 8.2% to 8.3%, the U.S. Labor Department said. Last month, nonfarm employment increased 163,000.
Financial advisers should prepare clients for tax-law changes
Because of disagreement between Democrats and Republicans about how to handle the impending expiration of Bush-era tax cuts, financial advisers should prepare clients for last-minute changes to U.S. tax law, experts said. Investors must be ready to change portfolios and estate plans to minimize taxes under a wide range of scenarios.
Geopolitical/Regulatory
SEC round table will discuss HFT issues, Schapiro says
Mary Schapiro, chairman of the Securities and Exchange Commission, said the agency will hold a round table soon to discuss "critical issues" related to Knight Capital Group's error and high-frequency trading. Schapiro also said the SEC is considering rules to tackle such issues. "I have asked the staff to accelerate ongoing efforts to propose a rule to require exchanges and other market centers to have specific programs in place to ensure the capacity and integrity of their systems," she said.
Vietnam moves to relax stock market rules to encourage investment
The Vietnamese State Securities Commission plans to increase initial public offerings of state-owned businesses and relax stock-trading rules to attract investment. The commission is expected to open the door to 100% foreign-owned securities firms. Vietnam's benchmark VN Index is the third-best-performing equity index this year in Asia.
Libor investigation zeros in on former Barclays swaps trader
An investigation into possible manipulation of the London Interbank Offered Rate has turned its focus to a 30-year-old former swaps trader at Barclays in New York. U.S. prosecutors are exploring activity by Ryan Reich, who was fired in 2010. Reich and Barclays declined to comment.
Financial Products
Fidelity reportedly readies actively managed sector ETFs
Fidelity Investments is getting ready to move into exchange-traded funds, with a series of actively managed sector funds, a source said. The company wants to be the first major mutual fund firm to offer ETFs whose investments are directed by active stock pickers.
According to the report by CNET, the tech website has contacted NPD DisplaySearch analyst Paul Semenza and he states, "We expect panel production to start in August, with production ramping up to high volumes (more than a million units per month) in the fourth quarter."
The report goes on to state, "Semenza said this is DisplaySearch's "understanding of the activity for the 7.85 [inch] panel expected to be used in the iPad Mini. If this production schedule plays out, it could indicate a late 2012 launch", he said."
If this report is true then we could see the tablet launched before the year ends. This report falls in line with another report that surfaced a few days ago, which indicated that Apple would host a special event for the iPad mini.
A few days ago, news started doing the rounds claiming that the iPad mini will launch at the same time as the next iPhone. However, Apple would likely intend to keep the spotlight fixed on the next iPhone aka the iPhone 5 as it will be nearly a year since they launched the iPhone 4S and are now facing increased competition from the likes of Samsung.
Samsung have successfully launched the Galaxy S III and have recorded over 10 million units sold. The brand also intends to unveil the Galaxy Note 2, a successor to the Galaxy Note by the end of August.
This would certainly put pressure on Apple as they usually launch just a single smartphone in a calendar year. Samsung has a whole line up of devices that aim to compete with the iPhone and if Apple does launch the iPad mini at the same time, it will take some of the shine off the iPhone 5, which it definitely does need.
The iPad mini is expected to feature a display of 7.85-inches and will compete directly against the Google Nexus 7, the 7-inch flagship Google tablet which is doing really well in the market.
This smaller iPad is also expected to feature a smaller dock connector and a microphone at the back. The microphone on the rear will assist the device in noise cancellation during video calls that can be done using Apple’s FaceTime or through Skype.
As erotic movie Jism 2 has not released yet and there is a lot of buzz about a porn star Sunny Leone and her bold erotic uncensored scenes. Youth are awaiting to watch bold,hot and sexy porn star Sunny Leone in Pooja Bhatt's 'Jism 2' but the actress-turned-director has started working on the third film in 'Jism' franchise, with plans to make it in 3D.
"I had my script ready a long time back. I want to get it out of my system. I will make 'Jism 3' in 3D. It will be interesting to make an erotic film in 3D," Pooja told IANS."In fact we had plans to make 'Jism 2' in 3D. But later we felt it would look very ahead of times," she added.
Indo-Brazilian Nathalia Kaur to lead in "Jism 3", may be Indo-canadian star Sunny Leone hasn't deliver the best in Jism 2
Ram Gopal Varma's discovery Nathalia Kaur will now be seen in Pooja Bhatt's next directorial venture 'Jism 3'. While 'Jism' had Bipasha Basu in a sizzling hot avatar, the just released second installment saw adult star Sunny Leone. 'Jism 3' will have not one but two actresses and Nathalia will be one of them.Incidentally, Pooja shot with Nathalia for the poster of the Sunny Leone-Randeep Hooda starrer. "When it was revealed that it was Nathalia who shot for the poster, Mahesh Bhatt saab texted me about casting her in the next installment. You just can't ignore his suggestions."
Asked if Sunny, too, will feature in 'Jism 3', Pooja says, "It is too early to tell. When I was making the second film, everyone asked if Bipasha would be in it and now everyone is asking if Sunny will be in the next.
Who is Nathalia Kaur?
Nathalia Kaur, also known as Nathalia Pinheiro, is an Indian Brazilian Model, Bollywood actress and a trained Opera singer
Nathalia Kaur was crowned as the Kingfisher Calendar Girl at 2012. She made her debut in the Kannada film Dev Son of Mudde Gowda directed by Indrajit Lankesh. Before her first film was released she was chosen by popular Bollywood director Ram Gopal Varma to do an item song Dan Danfor his next film. Earlier Sunny Leone was to do the song but due to her contract for the film Jism 2, Varma replaced her with Kaur. Ram Gopal Varma, who was always admitted himself to be an admirer of the beauty of a woman was overwhelmed by the actress and said that he had never seen a woman more beautiful than Nathalia in his entire life, not only his career. It is said that Ram Gopal Varma cast her as the heroine for his next film called Andam along with Rana Daggubati.
(IANS, Mid-Day, www.nathaliakaur.com)
Bollywood actor Uday Chopra is all set to launch a new label of comic books, 'Yomics', based on Yash Raj movies like 'Dhoom' and 'Ek Tha Tiger'. The actor says that it is his passion for comics and graphic novels which has led him to embark on this endeavour.
"I love reading comics and it's my passion. Most people don't want to get into this (comics) because they don't want to put money into it. But I feel if I am able to create an industry which doesn't exist today, I will be the one to start it. But more than that, it is the love for comics which has led me to this," he said at the launch of 'Yomics' at Yash Raj Studios Tuesday.
 |
| Ek tha tiger from yomics.in |
There are four titles which are ready as of now; 'Dhoom', 'Ek Tha Tiger', 'Hum Tum' and a new character based comic called Daya Prochu. The actor says that the fifth title is in the pipeline and will be introduced during Diwali.
"Every month a new 'Yomic' will come. We will be adding the fifth title during Diwali. The new title is very different to 'Dhoom' and 'Ek tha tiger'. I want to give the readers something completely new," he said.
Daya Prochu is an original addition by Uday Chopra. He is shown to be a fun school-going boy and Chopra feels that everyone will be able to relate to him.
"Daya is a school child and his thoughts are different. We all have a Daya Prochu in us. We have all been bullied, but his character bullies other people. It's a fun character," he added.
Talking about the impact of his venture, Chopra says that it purely depends on how the audience accept this medium. He is introducing four titles together in the hope that different people will associate to and like different characters and will like to read more about them.
"The success of any skill depends on the audience. I am bringing out four titles together so that they might like at least one. They might identify with at least one character and people will like to read their stories. I will keep at it for a while," he added.
Chopra said his 'Yomics' are very different to conventional comic books which are available. Their look and feel makes them distinct.
"I have kept the art work very colourful and simple. It is not grim. Today's comics are very grim and dark. I want to stay away from that. I want to cater to a universal audience and make them feel happy about it. I will enter that realm also but right now I want to make them very appealing," he said.
The Yash Raj banner is known for its love sagas and these surely will not be kept out of their comic books. Chopra plans to introduce them eventually.
"I have thought about it. I don't know how they will do in a comic book format. This format needs action to get moving. But in the west they don't only have action comic books and I don't see any reason for not doing that here. We will love to do it in a while," he added
Hidden Gem: Lincoln Pharmaceuticals Ltd Currently trading at Rs 27/ - EPS 4/- Target 45/- & 65/-
Buy Lincoln Pharmaceuticals Ltd at 27/- EPS 4/- Target 45/- & 65/-
Lincoln Pharmaceuticals Ltd. is another Natco Pharma Ltd (NATCO Pharma Ltd was recommended NATCO at 45/- 3 years back Now 357/- and touched 435/- means 10 times in 3 years; Like Natco Pharma Lincoln Pharma also move in Short term and Medium term TO 65/- & 150/-.)
Buy in for your Portfolio and get good returns in short term.
USFDA Approval News coming soon; its good Value Buy at this rate 27/- to 28/-.
Lincoln Pharmaceuticals Ltd Having Valuable Land in Ahmadabad nearly 7 Acres Value is nearly 21 Cr. Equity is just 11 Cr.
BUY LINCOLN PHARMACEUTICALS Ltd; doing Pharma Business; Stock Trading in BSE (Code : 531633) only . EPS 4/- Book Value 49/- PE just 7, Pharma Industry Avarage PE was 17; But this stock trading with PE just 7; If we take low PE 10 it will go 45/- ++; Equity 11 Cr; Every Year Dividend giving company from last 5 years onwards 12% means Rs. 1.2/- per share. Promoters Holding 39.78% Corporate Bodies 12.4% Public only 40% Target 65/- & 85/- within Short time.
Market may touch NIFTY 5,350 and BSE Sensex 17,500 SOON; FII's are hevily buying stage. Use this correction time for Buy LINCOLN PHARMACEUTICALS Ltd at 27/- Just Buy and hold 10 DAYS with good appreciation at 50% Profit because company having USFDA Approval Announcement and good EPS 4/- and good Book value at 49/- Good Dividend Paying company and company having strong fundamentals .
Recently Company allotted Preferential shares at 50/- So this stock is very valuable stock with risk free investment at 27/- . EPS 4/- Book value 49/- and Good Dividend paying Company.
Good Valuable Buy LINCOLN PHARMACEUTICALS Ltd. 10/- face Value Trading at 27/- with Target of 45/-. Risk is very very less because company stock was very Valuable because Book value at 49/ and Expecting EPS 6/- for 2012-2013. In Pharma sector average PE was 17, if you take this 17 Stock will come 90/- If u take minimum PE 10 It will come 65/- Equity 11cr. Just Buy and hold 1 month to 6 months with good appreciation at 100% Profit.
Lot of Accumulation is going on in BSE by Company circle people and operators Because Company engaged in Pharma and stock has good valuable at 31/- and less Equity 11 cr. Good Dividend Paying company. Check Delivery everyday 90% above.
LINCOLN PHARMACEUTICALS Ltd recorded total Revenues of 177 Crores and Net Profit 4.91 Cr for the year 2011-12 asn Expecting Revenue for 2012-13 is 230 Cr and net profit is 6.9 Cr based on this EPS will 6/- above because Expansion Income will add this year.
No Pharma Dividend Paying Company is trading in BSE or NSE with PE 6. Because Avarage PE fort Pharma is 17. But this Lincoln Pharma trading at 6 PE with EPS 4/- this year. Its very good future for this stock, No risk at 27/- Just Buy at 27/- Soon will touch 65/- & 75/-. Preferential Shares also given at 50/- recently. Its come Another NATCO PHARMA soonl NATCO I have Recommended at 45/- 3 years back now 357/- after tocuh 445/- measn 10 times return in 3 years, Same like NATCO this Lincoln Pharma will raise soon…
Share Holding:-
The Promoters holding 39.78%, Corporate bodies hold 12.4%, and Public only 40% .
Lincoln Pharmaceuticals is amongst the top world class quality oriented pharmaceutical producers, manufacturing and marketing various therapeutic molecules under WHO-GMP guidelines.Lincoln Pharmaceuticals Limited has pledged to serve the Health care segments, by providing Quality Pharmaceuticals at affordable prices.
Indian Pharmaceutical Industry is growing fast as far as export market is concerned, During last five years, there is a tremendous growth in the pharmaceutical industry. Lincoln Pharmaceuticals Limited has made successful achievement in overseas network for its formulations.
Lincoln Pharmaceuticals Ltd. has obtained drug registration for about 100 of its pharmaceuticals formulations in more than 10 African as well as in other countries too.
Kenya, Tanzania, Zimbabwe, Nigeria, Uganda, Sri Lanka, United Kingdom, Zambia, Republic of Yemen, Mauritius, Thailand, Ethiopia, Ghana.
Company View International Products
Company future planning is to expand business in following areas. We invite the interested parties from following countries who can represent our company and can explore business.
Carribean Islands,Central America,Latin America
Company plant facilities is certified by WHO GMP authorities as well as by ISO 9002. Company manufacture neutral label products for International Pharma Marketing companies. Company invite companies for contract manufacturing to produce their products.
See calls earned 50% to 300% for the Short term.
1) SE Investments given at 170/- Reached at 375/-
2) Techtran Poly given at 13/- Reached 21/-
3) Suraj Diamonds Given at 38/- reached 55/-
4) Bihar Tubes given at 57/- Reached at 105/-
5) Ponni Sugars given at 55/- Reached 175/-;
6) Pitti Laminations at 39/- Touched 99/-
7) Venus Power given at 8/- Reached 25/-
8) Comp-U-Learn given at 10/- reached 21/-
9) Natco Pharma given at 45/- Reached 445/-
10) Granules India given at 65/- Reached 150/- in very short Period.
11) IDL Industries given at 65/- Reached 99/-
12) Lanco Infra given at 10/- Reached 24/- But now 13/- Every down side at 10/- buy and hold.
13) Vikas WSP given at 15/- Reached 67/-
14) Usher Agro given at 27/- reached 115/-
Positive Points for this stock for Up moving:
1) Company is in Pharma Business; company Circle people and Operators are accumulating at current price. Because Company Stock Good Value at 27/- EPS 4/- PE 6 and Book Value at 49/- Equity is very small at 11Cr promoters Holding 39.78%
2) In Pharma Stocks Average PE was 17 But this stock trading with PE 6; If you take minimum 10 PE it will go 45/- minimum.
3) 12% Dividend Paying Company; September 19th is the Book Closure for Dividend.
4) Small Equity with good promoters Holding and having lot of Reserves and Good Book Value.
5) Lincoln Pharmaceuticals Ltd Having Valuable Land in Ahmadabad nearly 7 Acres Value is nearly 21 Cr. Equity is just 11 Cr.
6) USFDA Approval Announcement by next week.
7) Company having lot of Expansion Plans.
8) For this year Expected Revenue 230 Cr and Net Profit 6.9 Cr EPS 6.5/- PE 4.
9) Company Having good land bank near to Ahmedabad.
Happy Invest ……….. Good Fundamentals and will give good returns from 100% to 300% returns with short and medium terms and Long terms.
The 27-year-old is said to be currently dating singer John Mayer, reported Sun Online.
“I obviously have a lot to say right now. I’m a woman who likes to be courted— strongly. Never say never, I guess you’d say. I’ll let love take the lead on that,” she said.
The star hinted that while she is hailed as the candy princess, she will eventually have to hand over her tiara and move on to something new.
“I love what I do, and when I don’t love what I do, I’ll make a change, I can’t be the candy queen forever,” Perry said.
The singer also said she has no regrets in life and she doesn’t stress about the fact that she is a role model to many.
“I have no regrets. I’m not going to be everything to everyone. I can’t tell a person when it’s time for them to have sex. Or if they should have a cigarette. But I try to live my life with a lot of integrity, and, hopefully, that sends a message.”
( PTI )
Designed to address the problems women face in their private parts, Clean and Dry Intimate Wash offers protection, fairness and freshness. To be used while showering, its special pH-balanced formula cleans and protects the affected area, and even makes the skin fairer. Life for women will now be fresher, cleaner, fairer!
Our fairness obsession – at least in ad campaigns – now borders the ridiculous.
The fairer sex is now required to be literally so: fairer all over, all the time, from our pretty white brow to our bleached little toe, be it in the boardroom or the bedroom. The campaign to eliminate the scourge of darkness has extended to every nook and cranny of a woman’s body. A tiny little tan line? Perish the thought, says Anushka Sharma, as she flaunts her pristinely white finger. Tanned legs from playing tennis? Oh, the horror! As for the female underarm – long tortured and bruised by repeated waxing – the required hue is now a dazzling white once reserved for toilets and sports uniforms.
With women – socialised to fret over their appearance – the Fear Factor always works better. Reuters
So it was only a matter of time before we breached the final frontier: our long-neglectedyonis. Begone nasty purples, reds, and dark (Eeks, there is that word again!) pinks, cried the douche fairy. Let there be white, instead!
Do I think it’s dumb? Sure. For starters, none of the usual rationale of fairness product ads work here. While white is indeed right in the marriage market, this is one virtue that is difficult to list in that matrimonial ad: Khatri girl, 5’3″, convent education, working in MNC, slim, fair everywhere! And flashing your prospective employers is certainly not going to help you land that fancy, corporate job.
As for the bedroom, if a guy (or girl, if that’s the way you swing) is actually looking at your vagina, I can safely promise you, he’s not concerned with its exact hue. And if he is — brace yourself! — the boy’s most likely gay. The Indian male criteria for nookie is pretty straight-forward. He’s virtuously colour-blind if a) you’re pretty; or b) have big tits; or c) if you’re willing put out — in which case, he absolutely, incontrovertibly doesn’t give a damn!
So why bother with a fair and lovely douche?
Ask an advertising honcho like Alyque Padamsee, and you’ll likely get some version of this bit of received wisdom:
It is hard to deny that fairness creams often get social commentators and activists all worked up. What they should do is take a deep breath and think again. Lipstick is used to make your lips redder, fairness cream is used to make you fairer—so what’s the problem? I don’t think any Youngistani today thinks the British Raj/White man is superior to us Brown folk. That’s all 1947 thinking!
( Firstpost )
Sunny Leone says No to Big Boss
It was her big ticket to Bollywood - but Indo-Canadian porn star Sunny Leone says she would never go back to the 'Bigg Boss' house. Sunny told IANS: "I would never go back to the house again...it is insane, it is crazy. But what it did for me is it opened the doors, opened a new world - something that I had never imagined."
The actress is foraying into Bollywood with 'Jism 2', which was offered to her by Mahesh Bhatt while she was in the "Big Boss" house.
"Bhatt saab came in the house and talked about doing a movie, this idea never crossed my mind. I thought I will exit the house and never come back to India... but complete opposite thing happened," she added.
Sunny says the reality shows in West are completely different from what we see in India. "If you compare the reality shows here to there (US), here those who come on the show become very popular and achieve huge success.
"In America, if you do a reality show, they don't care. They don't identify people when they walk on streets, but here it does happen like that," explained the 31-year-old.
Releasing Aug 3, 'Jism 2' has been directed by Pooja Bhatt and Sunny will be seen romancing Arunoday Singh and Randeep Hooda in it. ( IANS )
New hot erotic "Hey Walla" song from Jism 2
Sunny Leone asked for Randeep, Arunoday's medical reports
The actress apparently demanded to see medical certificates of her co-stars Randeep Hooda and Arunoday Singh before agreeing to shoot intimate scenes with them.
Ever since Sunny Leone signed the dotted lines for Pooja Bhatt's upcoming film co-starring Randeep Hooda and Arunoday Singh, she has consistently made headlines.
This will be her first Bollywood film, and buzz is that before shooting for the project, Sunny put a condition in front of Pooja. Apparently, the adult film actress demanded to see medical certificates of both her co-stars.
A source close to the film says, "Before Sunny was to join the cast and crew to shoot her portions, she sent an e-mail to Pooja demanding a medical certificate of Randeep and Arunoday with whom she was scheduled to shoot lovemaking sequences. In all fairness she also sent her own medical certificate. Basically, she wanted to make sure that she was not going to shoot with anyone who had any life threatening disease (Read HIV)."
The source explains, "Pooja Bhatt then told her that this was not the norm in Bollywood unlike for the adult films that Sunny does. The director also explained to her that she would not require to film sequences that she normally shoots for her adult films."
Finally, apparently no such medical certificate was shown to Sunny. The source states, "No one is aware what exactly happened and how Pooja convinced her." We wonder what Randeep and Arunoday had to say about this surprising demand. Pooja Bhatt remained unavailable for comment. (Mid -Day)
Porn Star Sunny Leone's Lingerie to be auctioned..
Director of 'Jism 2' Pooja Bhatt has decided to auction her lead cast's clothes, including undergarments for charity. Makers of the film lately tweeted "@Jism2 Sunny Leone's lingerie along with other clothes of her and other actors up for auction for charity... any takers?"
Porn star Sunny Leone will make her Bollywood debut with 'Jism 2'. Bollywood actors Randeep Hooda and Arunoday Singh will be seen sharing screen space with Sunny in the film. During an interview lately, Pooja Bhatt said that she is auctioning Sunny, Randeep and Arunoday’s entire wardrobe, including their underwear.
Sunny Leone was chosen for the film while she came to India to participate in a popular reality show 'Bigg Boss 5'. Since then, there has been no looking back for the stunning lady.
Pooja Bhatt can't wait to release her film. Instead of August 3, 'Jism 2' will now be released on July 27, 2012. 'Jism 2', a sequel to 2003 film 'Jism', will see Sunny as seductress Izna.
The first song from Sunny Leone, Randeep Hooda and Arunoday Singh starrer 'Jism 2' is out now. As the censor board gave an 'A' rating to the video, director Pooja Bhatt decided to release it on the internet. 'Jism 2' is one of the most awaited films of 2012 as it marks the debut of porn star Sunny Leone in Bollywood.
Ever since Sunny Leone signed the dotted lines for Pooja Bhatt's upcoming film co-starring Randeep Hooda and Arunoday Singh, she has consistently made headlines.
This will be her first Bollywood film, and buzz is that before shooting for the project, Sunny put a condition in front of Pooja. Apparently, the adult film actress demanded to see medical certificates of both her co-stars.
A source close to the film says, "Before Sunny was to join the cast and crew to shoot her portions, she sent an e-mail to Pooja demanding a medical certificate of Randeep and Arunoday with whom she was scheduled to shoot lovemaking sequences. In all fairness she also sent her own medical certificate. Basically, she wanted to make sure that she was not going to shoot with anyone who had any life threatening disease (Read HIV)."
The source explains, "Pooja Bhatt then told her that this was not the norm in Bollywood unlike for the adult films that Sunny does. The director also explained to her that she would not require to film sequences that she normally shoots for her adult films."
Finally, apparently no such medical certificate was shown to Sunny. The source states, "No one is aware what exactly happened and how Pooja convinced her." We wonder what Randeep and Arunoday had to say about this surprising demand. Pooja Bhatt remained unavailable for comment. (Mid -Day)
Porn Star Sunny Leone's Lingerie to be auctioned..
Director of 'Jism 2' Pooja Bhatt has decided to auction her lead cast's clothes, including undergarments for charity. Makers of the film lately tweeted "@Jism2 Sunny Leone's lingerie along with other clothes of her and other actors up for auction for charity... any takers?"
Porn star Sunny Leone will make her Bollywood debut with 'Jism 2'. Bollywood actors Randeep Hooda and Arunoday Singh will be seen sharing screen space with Sunny in the film. During an interview lately, Pooja Bhatt said that she is auctioning Sunny, Randeep and Arunoday’s entire wardrobe, including their underwear.Sunny Leone was chosen for the film while she came to India to participate in a popular reality show 'Bigg Boss 5'. Since then, there has been no looking back for the stunning lady.
Pooja Bhatt can't wait to release her film. Instead of August 3, 'Jism 2' will now be released on July 27, 2012. 'Jism 2', a sequel to 2003 film 'Jism', will see Sunny as seductress Izna.
The first song from Sunny Leone, Randeep Hooda and Arunoday Singh starrer 'Jism 2' is out now. As the censor board gave an 'A' rating to the video, director Pooja Bhatt decided to release it on the internet. 'Jism 2' is one of the most awaited films of 2012 as it marks the debut of porn star Sunny Leone in Bollywood.
A new song 'Maula' from 'Jism 2' starring Sunny Leone and Randeep Hooda was released on July 4 but slowly climbed up the popularity chart because of its earthy beat and lilting music.
The title song of the film 'Jism 2' is composed by Arko Pravo Mukherjee and has vocals by Ali Azmat. The lyrics are by Mukherjee and Munish Makhija.
The Pooja Bhatt film revolves around the story of an adult film star hired by a dashing intelligence officer to become a 'honey-trap' for a dreaded assassin. In doing so, she not only has to confront her bitter-sweet past, but is also forced to make an impossible choice - one that will put her own life in double jeopardy.
After teasing audiences to several steamy song promos, director Pooja Bhatt released the theatrical trailer of her much talked-about project “Jism 2” on YouTube. The clip finally showcases the international porn star Sunny Leone’s acting skills.
( images jism2.com )
